CellaVision presents the first quarter 2017 on May
Post# of 301275
The information was submitted to the public on April 26, 2017 at 8:20 CET
CellaVision AB (publ) will publish the interim report for the first quarter on May 4, 2017 at 8:20 CET. The report will be available at www.cellavision.com
In connection with the release of the interim report analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CET where Zlatko Rihter, CEO, will present and comment the report.
The presentation will be in English via a conference call or audio webcast: https://tv.streamfabriken.com/cellavision-q1-2017
Phone number for the conference:
SE: +46 8 566 42 662
UK: +44 2 030 089 806
US: +1 8 558 315 944
No pre-registration is required. Please dial in 5-10 minutes prior to the scheduled start time in order to facilitate a timely start.
About CellaVision CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products replaces manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. Sales are via global partners with support from the parent company in Lund and by the market support organizations in the US, Canada, China, Sweden, Japan, Dubai, Korea, Australia and France. In 2016 sales were SEK 265 million and the company's growth target is 15 % per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq Stockholm, Small Cap list. Read more at www.cellavision.com
Attachments:
(0)
(0)